<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="correction" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2022.8463</article-id>
<article-id pub-id-type="publisher-id">OR-49-02-08463</article-id>
<article-categories>
<subj-group>
<subject>Corrigendum</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Liang</surname><given-names>Xinglin</given-names></name>
</contrib>
<contrib contrib-type="author"><name><surname>Xia</surname><given-names>Ruixiang</given-names></name>
</contrib>
</contrib-group>
<pub-date pub-type="collection">
<month>02</month>
<year>2023</year></pub-date>
<pub-date pub-type="epub">
<day>13</day>
<month>12</month>
<year>2022</year></pub-date>
<volume>49</volume>
<issue>2</issue>
<elocation-id>26</elocation-id>
<permissions>
<copyright-statement>Copyright: &#x00A9; Liang et al.</copyright-statement>
<copyright-year>2022</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 47: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="corrected-article" vol="47" page="18" id="RA1" xlink:href="10.3892/or.2021.8229" ext-link-type="doi">18</related-article>, 2022; DOI: 10.3892/or.2021.8229</p>
<p>Following the publication of the above article, the authors have realized that an error was made during the compilation of <xref rid="f9-or-49-02-08463" ref-type="fig">Fig. 9</xref>, as it appears on p. 10; essentially, the &#x03B2;-actin bands featured in <xref rid="f9-or-49-02-08463" ref-type="fig">Fig. 9A</xref> were inadvertently copied across to <xref rid="f9-or-49-02-08463" ref-type="fig">Fig. 9B</xref>.</p>
<p>The revised version of <xref rid="f9-or-49-02-08463" ref-type="fig">Fig. 9</xref>, now showing the correct &#x03B2;-actin bands for <xref rid="f9-or-49-02-08463" ref-type="fig">Fig. 9B</xref>, is shown on the next page. All the authors approve of the publication of this corrigendum, and the authors are grateful to the Editor of <italic>Oncology Reports</italic> for granting them the opportunity to publish this. The authors regret their oversight in allowing this error to be included in the published paper, and apologize to the readership for any inconvenience caused.</p>
</body>
<floats-group>
<fig id="f9-or-49-02-08463" position="float">
<label>Figure 9.</label>
<caption><p>Successful transfection of RhoA overexpression plasmid in AML cells. Western blot analysis of (A) KG-1 and (B) Kasumi-1 cells following RhoA overexpression. RhoA and ROCK1 protein expression levels in (C) KG-1 and (D) Kasumi-1 cells following RhoA overexpression. &#x002A;P&#x003C;0.05, &#x002A;&#x002A;P&#x003C;0.01. RhoA, ras homolog family member A; AML, acute myeloid leukemia; ROCK1, Rho associated coiled-coil containing protein kinase 1; NC, negative control; KIF2A, kinesin family member 2A; si, small interfering.</p></caption>
<graphic xlink:href="or-49-02-08463-g00.tif"/>
</fig>
</floats-group>
</article>
